ASBMT Clinical Research Training Course 2018

Park City, UT US
July 11, 2018 to July 16, 2018

The ASBMT Board of Directors created the course in 2006 because of concerns that clinical fellowship programs don’t adequately cover the principles of research and how to take findings from the laboratory to the clinic. The course helps close the gap by addressing those deficiencies. The course includes formal presentations and extensive follow-up dialogue and small-group discussion, covering topics such as:

  • Research subject eligibility and recruitment
  • Clinical trial design
  • Biostatistics
  • Data management and quality control
  • Study endpoints
  • Late effects and quality of life
  • Clinical pharmacology, including polypharmacy and drug interactions
  • Regulatory compliance
  • Relationships with pharmaceutical companies and third-party payers
  • Opportunities for grants and clinical research training
  • Grant writing
  • Working with a mentor
  • Translational trials
  • Working with laboratory investigators
  • Research ethics
  • Subject safety

Each participant will be expected to have a research project that can be developed in discussions with faculty and with peers.



The 2018 course directors are Christopher N. Bredeson, MD, MSc, The Ottawa Hospital/University of Ottawa and Margaret MacMillan, MD, MSc, University of Minnesota.

Faculty members will share their career stories and anecdotes. They will tell how they got where they are and the lessons learned along with way. Free time for rest, recreation and creative thinking will be built into the schedule.


Eligibility and Application

An applicant must be an ASBMT member or sponsored by an ASBMT member. For purposes of this program, "junior faculty” is defined as two years or less teaching in the BMT field.
The applicant must identify a local mentor with whom to work in implementation of the research project after the course.




This educational activity is being supported by:  Jazz Pharmaceuticals, Incyte, and Merck & Co. Inc.

Target Audience

Physicians and allied health professionals

Learning Objectives

At the conclusion of this activity, scholars should be able to: 

  • Provide Scholars with an opportunity to present their research to their peers and BMT Faculty
  • Provide Scholars with critical input regarding clinical trial design and implementation.
  • Prepare Scholars for presenting their research at national meetings 

  • Foster mentoring and networking between faculty and scholars in an intimate environment 

  • Reinforce participants’ commitment to the stem cell transplantation community



Additional information

CME Coordinator Contact Information

Kirk Lanzone Terry
Phone Number: 
+1 (312) 673-5563
Course summary
Available credit: 
  • 35.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 35.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
07/11/2018 - 2:00pm
Event ends: 
07/16/2018 - 9:30am
Hotel Park City
2001 Park Ave
Park City, UT 84060
United States
+1 (435) 200-2000
Planning Committee:
Christopher N. Bredeson, MD, MSc - University of Ottawa
Margaret MacMillan, MD - University of Minnesota
Corey Cutler, MD - Dana-Farber Cancer Institute
Daniel Couriel, MD - Huntsman Cancer Institute
Marcos De Lima, MD - University Hospitals - Seidman Cancer Center
Steven Devine, MD - Center for International Blood and Marrow Transplantation
Brenda Sandmaier, MD - Fred hutchinson Cancer Research Center/University of Washington
Joycelynn Palmer, PhD - (Course Statistician) City of Hope National Medical Center
Ted Gooley, PhD - (Course Statistician) Fred hutchinson Cancer Research Center
Partow Kebriaei, MD - MD Anderson Cancer Center
Carlos Almeida Ramos, MD - Baylor College of Medicine
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following and in accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved. 
Margaret MacMillian, MD
CSL Behring
Advisory Board
Brenda Sandmaier, MD
Pfizer, Kiadis, AnaptysBio
Carlos A. Ramos, MD
Tessa Therapeutics, Novartis, Celgene
PI, Advisory Board
Joycelynne Palmer, PhD
Gilead Sciences Inc.
Ted Gooley
Nohla Therapeutics, Pharmacyclics, Kiadis
Consultant, DMC Member
Marcos de Lima
Celgene, Pfizer, Kiadis
Advisory Board
Corey Cutler
Bristol-Myers Squibb, Pfizer, Astellas, Incyte, Jazz, ElsaLys
Daniel Couriel
Merck, Incyte, Seattle Genetics, Inc.
Advisory Board, Speaker
Christopher Bredeson
Otsuka, Celegene, Jazz, Kite Pharma
Advisory Board,
Matthew Frigault
Novartis, Celgene, Nkarta
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and American Society for Blood and Marrow Transplantation. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 35.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 35.25 hours of participation for continuing education for allied health professionals.

Available Credit

  • 35.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 35.25 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
Course expires: 


Please login or register to take this course.